These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

256 related items for PubMed ID: 22669506

  • 1. Flow cytometric quantification and immunophenotyping of leukemic stem cells in acute myeloid leukemia.
    Hwang K, Park CJ, Jang S, Chi HS, Kim DY, Lee JH, Lee JH, Lee KH, Im HJ, Seo JJ.
    Ann Hematol; 2012 Oct; 91(10):1541-6. PubMed ID: 22669506
    [Abstract] [Full Text] [Related]

  • 2. Enrichment of N-Cadherin and Tie2-bearing CD34+/CD38-/CD123+ leukemic stem cells by chemotherapy-resistance.
    Zhi L, Wang M, Rao Q, Yu F, Mi Y, Wang J.
    Cancer Lett; 2010 Oct 01; 296(1):65-73. PubMed ID: 20444543
    [Abstract] [Full Text] [Related]

  • 3. Immunoprofiling of leukemic stem cells CD34+/CD38-/CD123+ delineate FLT3/ITD-positive clones.
    Al-Mawali A, Gillis D, Lewis I.
    J Hematol Oncol; 2016 Jul 27; 9(1):61. PubMed ID: 27465508
    [Abstract] [Full Text] [Related]

  • 4. [The immunophenotypic analysis of CD7+ and (or) CD56+ acute myeloid leukemic stem cells and its applications in minimal residual disease detection].
    Cao H, Wang YZ, Wu HH, Chang Y, Hao L, Chen SS, Huang XJ, Lu DP, Liu YR.
    Zhonghua Xue Ye Xue Za Zhi; 2008 Jan 27; 29(1):23-8. PubMed ID: 18512311
    [Abstract] [Full Text] [Related]

  • 5. CD45dimCD34+CD38-CD133+ cells have the potential as leukemic stem cells in acute myeloid leukemia.
    Heo SK, Noh EK, Ju LJ, Sung JY, Jeong YK, Cheon J, Koh SJ, Min YJ, Choi Y, Jo JC.
    BMC Cancer; 2020 Apr 06; 20(1):285. PubMed ID: 32252668
    [Abstract] [Full Text] [Related]

  • 6. Resistance of leukemic stem-like cells in AML cell line KG1a to natural killer cell-mediated cytotoxicity.
    She M, Niu X, Chen X, Li J, Zhou M, He Y, Le Y, Guo K.
    Cancer Lett; 2012 May 28; 318(2):173-9. PubMed ID: 22198207
    [Abstract] [Full Text] [Related]

  • 7. [Analysis of immunophenotype and leukemia associated immunophenotype in 610 patients with acute myeloid leukemia].
    Liu YR, Wang YZ, Chen SS, Chang Y, Fu JY, Li LD, Wang H, Yu H, Jiang B, Huang XJ.
    Zhonghua Xue Ye Xue Za Zhi; 2007 Nov 28; 28(11):731-6. PubMed ID: 18457262
    [Abstract] [Full Text] [Related]

  • 8. High proportion of leukemic stem cells at diagnosis is correlated with unfavorable prognosis in childhood acute myeloid leukemia.
    Witte KE, Ahlers J, Schäfer I, André M, Kerst G, Scheel-Walter HG, Schwarze CP, Pfeiffer M, Lang P, Handgretinger R, Ebinger M.
    Pediatr Hematol Oncol; 2011 Mar 28; 28(2):91-9. PubMed ID: 21214408
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Identification of a small subpopulation of candidate leukemia-initiating cells in the side population of patients with acute myeloid leukemia.
    Moshaver B, van Rhenen A, Kelder A, van der Pol M, Terwijn M, Bachas C, Westra AH, Ossenkoppele GJ, Zweegman S, Schuurhuis GJ.
    Stem Cells; 2008 Dec 28; 26(12):3059-67. PubMed ID: 19096043
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Delineation of target expression profiles in CD34+/CD38- and CD34+/CD38+ stem and progenitor cells in AML and CML.
    Herrmann H, Sadovnik I, Eisenwort G, Rülicke T, Blatt K, Herndlhofer S, Willmann M, Stefanzl G, Baumgartner S, Greiner G, Schulenburg A, Mueller N, Rabitsch W, Bilban M, Hoermann G, Streubel B, Vallera DA, Sperr WR, Valent P.
    Blood Adv; 2020 Oct 27; 4(20):5118-5132. PubMed ID: 33085758
    [Abstract] [Full Text] [Related]

  • 18. HLA-G expression is irrelevant to prognosis in patients with acute myeloid leukemia.
    Guo QY, Chen BG, Ruan YY, Lin A, Yan WH.
    Leuk Res; 2011 Oct 27; 35(10):1350-4. PubMed ID: 21696824
    [Abstract] [Full Text] [Related]

  • 19. Antigen expression on a putative leukemic stem cell population and AML blast.
    Garg S, Ghosh K, Madkaikar M.
    Int J Hematol; 2016 May 27; 103(5):567-71. PubMed ID: 26910244
    [Abstract] [Full Text] [Related]

  • 20. Attenuation of microRNA-126 expression that drives CD34+38- stem/progenitor cells in acute myeloid leukemia leads to tumor eradication.
    de Leeuw DC, Denkers F, Olthof MC, Rutten AP, Pouwels W, Schuurhuis GJ, Ossenkoppele GJ, Smit L.
    Cancer Res; 2014 Apr 01; 74(7):2094-105. PubMed ID: 24477595
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.